Skip to main content

02 · Clinical Findings

Los medicamentos GLP-1 pueden ayudar a revertir la prediabetes, según un estudio

Infobae Salud1 min read

A medical-record review in adults with obesity and prediabetes also linked GLP-1 drugs to a 31% lower risk of type 2 diabetes than metformin.

Image from the article by Infobae Salud: Los medicamentos GLP-1 pueden ayudar a revertir la prediabetes, según un estudio
Image: Infobae Salud

Could GLP-1 drugs help turn back prediabetes? A medical-record review linked them to better outcomes than metformin in adults with obesity and prediabetes.

Those receiving GLP-1 drugs were 53% more likely to regain normal blood sugar and had a 31% lower risk of developing type 2 diabetes.

The findings are due for presentation at an AHA meeting. Researchers emphasized that diet and exercise remain essential, while metformin remains a first-line option.

DisclaimerEducational news and research awareness content. Not medical advice.Read full disclaimer ▾

This page shares third-party news coverage, official research listings, and public clinical updates for educational awareness only. Catalyst does not present this information as medical advice, treatment guidance, or a claim of safety, efficacy, or approval.

Related context

How this story connects across the peptide landscape.

Continue reading · Clinical FindingsPeptide News / Clinical FindingsMenopausal Hormone Therapy May Boost GLP-1 Weight LossMedPage Today · Oct 27, 2026 · scroll to read